Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Share-based Compensation (2020 - 2025)

Definitive Healthcare's Share-based Compensation history spans 6 years, with the latest figure at $8.2 million for Q4 2025.

  • For Q4 2025, Share-based Compensation rose 10.81% year-over-year to $8.2 million; the TTM value through Dec 2025 reached $29.1 million, down 23.48%, while the annual FY2025 figure was $29.1 million, 23.48% down from the prior year.
  • Share-based Compensation reached $8.2 million in Q4 2025 per DH's latest filing, up from $6.7 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $15.6 million in Q1 2024 to a low of $406000.0 in Q1 2021.
  • Average Share-based Compensation over 5 years is $8.1 million, with a median of $7.8 million recorded in 2024.
  • Peak YoY movement for Share-based Compensation: soared 1592.61% in 2022, then plummeted 53.03% in 2025.
  • A 5-year view of Share-based Compensation shows it stood at $5.6 million in 2021, then soared by 103.31% to $11.4 million in 2022, then grew by 16.02% to $13.3 million in 2023, then plummeted by 44.43% to $7.4 million in 2024, then rose by 10.81% to $8.2 million in 2025.
  • Per Business Quant, the three most recent readings for DH's Share-based Compensation are $8.2 million (Q4 2025), $6.7 million (Q3 2025), and $7.0 million (Q2 2025).